Differences in adverse events between 250mg daily gefitinib and 150mg daily erlotinib in Japanese patients with non-small cell lung cancer

DOI Web Site Web Site 2 Citations

Journal

  • Lung Cancer

    Lung Cancer 74 (1), 98-102, 2011-10

    Elsevier BV

Citations (2)*help

See more

Keywords

Report a problem

Back to top